Top Interviews from 2023 ACTRIMS: Expert Insights on Multiple Sclerosis

Article

A group of experts in the care of patients with multiple sclerosis—Marisa McGinley, DO; Farrah Mateen, MD, PhD; Laura Piccio, MD, PhD; Robert Zivadinov, MD, PhD; and Bruce Cree, MD, PhD, MAS, FAAN—shared their perspectives on hot topics of treatment and management from the 2023 ACTRIMS Forum.

In recent months, the NeurologyLive® staff has spoken to a variety of experts in the clinical care and management of patients with multiple sclerosis (MS), including those with relapsing-remitting MS and other related autoimmune disorders such as neuromyelitis optica spectrum disorder (NMOSD).

To recap the 2023 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, February 23-25, in San Diego, California, NeurologyLive® compiled a number of interviews with experts from the Forum to offer an overview of the state of care and discussions on the hottest topics in MS. Those featured include:

  • Marisa McGinley, DO, staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic
  • Farrah Mateen, MD, PhD, associate professor at Harvard Medical School and associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital
  • Laura Piccio, MD, PhD, a neurologist and physician scientist at Washington University in St. Louis
  • Robert Zivadinov, MD, PhD, director of the Buffalo Neuroimaging Analysis Center
  • Bruce Cree, MD, PhD, MAS, FAAN, clinical research director of the UCSF Multiple Sclerosis Center

Click here for more coverage of the ACTRIMS 2023.

Click through the slides below to check out each expert interview:


—————————————————

Related Videos
Sanjay R. Patel, MD, MS
Patricia K. Coyle, MD
Video 2 - 5 KOLs are featured in "Natural History of Spinal Muscular Atrophy"
Video 1 - 5 KOLs are featured in "Clinical Features and Phenotypes of Spinal Muscular Atrophy"
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
© 2024 MJH Life Sciences

All rights reserved.